From Imaging the Brain to Imaging the Retina: Optical Coherence Tomography (OCT) in Schizophrenia

Schizophrenia Bulletin

Volumn 42, Issue 1, 2016, Pages 9-14

  Schönfeldt Lecuona, Carlos ^a   Kregel, Thomas ^a   Schmidt, Arno ^a   Pinkhardt, Elmar H ^a   Lauda, Florian ^a   Kassubek, Jan ^a   Connemann, Bernhard J ^a   Freudenmann, Roland W ^a   Gahr, Maximilian ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

degeneration; macula volume; neuroimaging; psychiatric disorders; retinal nerve fibre layer; visual impairment

Indexed keywords

AXON; BRAIN; DEGENERATIVE DISEASE; HUMAN; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; ORGAN SIZE; PATHOLOGY; RETINA; RETINA MACULA LUTEA; SCHIZOPHRENIA; VISUAL SYSTEM;

AXONS; BRAIN; HUMANS; MACULA LUTEA; NERVE FIBERS; NEURODEGENERATIVE DISEASES; ORGAN SIZE; RETINA; SCHIZOPHRENIA; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL PATHWAYS;

EID: 84954341731     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv073     Document Type: Article

References (55)

1. London A, Benhar I, Schwartz M. The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol. 2013;9:44-53.
2. Galetta KM, Calabresi PA, Frohman EM, Balcer LJ. Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics. 2011;8:117-132.
3. Simao LM. The contribution of optical coherence tomography in neurodegenerative diseases. Curr Opin Ophthalmol. 2013;24:521-527.
4. Jindahra P, Hedges TR, Mendoza-Santiesteban CE, Plant GT. Optical coherence tomography of the retina: applications in neurology. Curr Opin Neurol. 2010;23:16-23.
5. Tzekov R, Mullan M. Vision function abnormalities in Alzheimer disease. Surv Ophthalmol. 2014;59:414-433.
6. Archibald NK, Clarke MP, Mosimann UP, Burn DJ. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov Disord. 2011;26:2387-2395.
7. Graves J, Balcer LJ. Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol. 2010;4:1409-1422.
8. Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain. 2001;124:1813-1820.
9. Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005;4:111-121.
10. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 2006;113:324-332.
11. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69:1603-1609.
12. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci. 2008;268:12-17.
13. Kim JS, Ishikawa H, Sung KR, et al. Retinal nerve fibre layer thickness measurement reproducibility improved with spectral domain optical coherence tomography. Br J Ophthalmol. 2009;93:1057-1063.
14. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: A window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol. 2008;4:664-675.
15. Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Threedimensional retinal imaging with high-speed ultrahighresolution optical coherence tomography. Ophthalmology. 2005;112:1734-1746.
16. Leitgeb R, Hitzenberger C, Fercher A. Performance of fourier domain vs. time domain optical coherence tomography. Opt Express. 2003;11:889-894.
17. Chen J, Lee L. Clinical applications and new developments of optical coherence tomography: an evidence-based review. Clin Exp Optom. 2007;90:317-335.
18. Schneider M, Müller HP, Lauda F, et al. Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm. 2014;121:41-47.
19. Ding Y, Spund B, Glazman S, et al. Application of an OCT data-based mathematical model of the foveal pit in Parkinson disease. J Neural Transm. 2014;121:1367-1376.
20. Bodis-Wollner I, Miri S, Glazman S. Venturing into the noman's land of the retina in Parkinson's disease: review of OCT in Parkinson's disease. Mov Disord. 2014;29:15-22.
21. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
22. Blumenthal EZ, Parikh RS, Pe'er J, et al. Retinal nerve fibre layer imaging compared with histological measurements in a human eye. Eye (Lond). 2009;23:171-175.
23. Fujimoto JG. Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol. 2003;21:1361-1367.
24. Schuman JS, Hee MR, Arya AV, et al. Optical coherence tomography: A new tool for glaucoma diagnosis. Curr Opin Ophthalmol. 1995;6:89-95.
25. Coker JG, Duker JS. Macular disease and optical coherence tomography. Curr Opin Ophthalmol. 1996;7:33-38.
26. Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134:518-533.
27. He XF, Liu YT, Peng C, Zhang F, Zhuang S, Zhang JS. Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer's disease: A meta-analysis. Int J Ophthalmol. 2012;5:401-405.
28. Cetin EN, Bir LS, Sarac G, Yaldizkaya F, Yaylali V. Optic disc and retinal nerve fibre layer changes in Parkinson's disease. J Neuroophthalmology. 2013;37:20-23.
29. Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012;135:521-533.
30. Albrecht P, Müller AK, Südmeyer M, et al. Optical coherence tomography in parkinsonian syndromes. PLoS One. 2012;7:e34891.
31. Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in MS. Ann Neurol 2010;67:749-760.
32. Fercher AF. Optical coherence tomography-development, principles, applications. Z Med Phys. 2010;20:251-276.
33. Cettomai D, Pulicken M, Gordon-Lipkin E, et al. Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol. 2008;65:1218-1222.
34. Butler PD, Javitt DC. Early-stage visual processing deficits in schizophrenia. Curr Opin Psychiatry. 2005;18:151-157.
35. Merigan WH, Maunsell JH. How parallel are the primate visual pathways? Annu Rev Neurosci. 1993;16:369-402.
36. Balogh Z, Benedek G, Kéri S. Retinal dysfunctions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:297-300.
37. Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu JM, Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biol Psychiatry. 2014;75:479-486.
38. Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends Neurosci. 1990;13:296-302.
39. Meier MH, Shalev I, Moffitt TE, et al. Microvascular abnormality in schizophrenia as shown by retinal imaging. Am J Psychiatry. 2013;170:1451-1459.
40. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry. 2011;70:88-96.
41. Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: A meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129-1138.
42. Glahn DC, Laird AR, Ellison-Wright I, et al. Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry. 2008;64:774-781.
43. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: A meta-analysis. Schizophr Res. 2010;117:1-12.
44. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122:593-624.
45. Byne W, Buchsbaum MS, Mattiace LA, et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry. 2002;159:59-65.
46. Young KA, Manaye KF, Liang C, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry. 2000;47:944-953.
47. Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry. 2000;48:641-650.
48. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/ Bcl-2 ratio without caspase-3 activation. Am J Psychiatry. 2004;161:109-115.
49. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res. 2006;81:47-63.
50. Pasternak O, Westin CF, Bouix S, et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci. 2012;32:17365-17372.
51. Polajnar M, Zerovnik E. Impaired autophagy: A link between neurodegenerative and neuropsychiatric diseases. J Cell Mol Med. 2014;18:1705-1711.
52. Ascaso FJ, Cabezon L, Quintanilla MA, et al. Retinal nerve fiber layer thickness measured by optical coherence tomography in patients with schizophrenia: A short report. Eur J Psychiat. 2010;24:227-235.
53. Cabezon L, Ascaso FJ, Ramiro P, et al. Optical coherence tomography: A window into the brain of schizophrenic patients. Acta Ophthalmol. 2012;90:0.
54. Chu EM, Kolappan M, Barnes TR, Joyce EM, Ron MA. A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res. 2012;203:89-94.
55. Lee WW, Tajunisah I, Sharmilla K, Peyman M, Subrayan V. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54:7785-7792.